FDA Abruptly Ends Emergency Use Authorization for Monoclonal Antibodies

This is a press release via the Florida Department of Health informing citizens that they will no longer be able to get monoclonal antibody treatment for Covid-19:

“This evening, without any advanced notice, the US Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) for bamlanivimad/etesevimab and REGEN-COV. The revised EUAs do not allow providers to administer these treatments within the United States.

Unfortunately, as a result of this abrupt decision made by the federal government, all monoclonal antibody state sites will be closed until further notice.

Florida disagrees with the decision that blocks access to any available treatments in the absence of clinical evidence. To date, such clinical evidence has not been provided by the FDA.

Even though this is a Florida Department of Health announcement, the FDA’s decision applies to the whole country. No more monoclonal antibodies for anyone in the US.

If there is a shortage in monoclonal antibodies, that’s one thing. But it does not appear the federal government has given any reason for this decision.

And at this point, they do not deserve the benefit of the doubt.

People will die because of this. If there is no shortage of monoclonal antibodies and the FDA is simply ending EUA because it wants to promote Big Pharma “solutions” to Covid-19 like Paxlovid and Remdesivir, this is nothing short of willful mass murder.

Leave a Reply